| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.034 | 0.8 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.049 | 0.8 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.015 | 0.8 |